Module 9: Sedative/Hypnotics and CNS Depressants
Module 9: References
Automobile Association of America (AAA). (2014). Fact sheet: Drugged driving. Retrieved from http://exchange.aaa.com/wp-content/uploads/2014/12/Prescription-and-Over-the-Counter-Impaired-Driving-Fact-Sheet.pdf
Dodds, T.J. (2017). Prescribed benzodiazepines and suicide risk: A review of the literature. The Primary Care Companion for CNS Disorders, 19(2), e1-e6. Retrieved from http://www.psychiatrist.com/PCC/article/Pages/2017/v19n02/16r02037.aspx doi: 10.4088/PCC.16r02037
Dupont, R.L., & Dupont, C.M. (2005). Sedatives/hypnotics and benzodiazepines. In R.J. Frances, S.I. Miller, & A.H. Mack, (Eds.), Clinical textbook of addictive disorders, third edition, (pp. 219-242). NY: Guilford Press.
Kripke, D. F., Langer, R.D., & Kline, L.E. (2012). Hypnotics’ association with mortality or cancer: A matched cohort. BMJ Open. doi: 10.1136/bmjopen-2012-000850.
National Institute on Drug Abuse (NIDA). (2014). DrugFacts: Club drugs (GHB, Ketamine, and Rohypnol). Retrieved from https://www.drugabuse.gov/sites/default/files/drugfacts_clubdrugs_12_2014.pdf
National Institute on Drug Abuse (NIDA). (2017). Overdose death rates. Retrieved from https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates
Volkow, N. (2010). Prescription drug abuse. Presented to the Congressional Caucus, September 22. Retrieved from https://www.drugabuse.gov/about-nida/legislative-activities/testimony-to-congress/2010/09/prescription-drug-abuse